Oliver Hill – Senior Director Protein Engineering, YUMAB GmbH Oliver Hill is an experienced biotechnology professional specializing in protein engineering and drug discovery. Currently, he serves as Senior Director of Protein Engineering at YUMAB GmbH, focusing on advancing antibody-based therapeutics for clients. Oliver has held leadership roles at TriCos Biotherapeutics and Apogenix AG, where he contributed to the development of innovative immuno-oncology platforms, including the HERA-technology. His work has supported the creation of promising therapies for cancer and immune-related diseases. With a career spanning over two decades, Oliver brings deep expertise in translating scientific innovation into tailored biologics. Learn more about his professional background on https://www.linkedin.com/in/olhill/.